Prestige Consumer Healthcare Inc - Understand $pbh stock

$PBH Market Cap: $4.09 Billion

Research Board Inbox Deep Research Not Interested Shortlisted

Financial Snapshot

Revenue

$1.111B

TTM

Gross Margin

55.2%

TTM

Net Earnings

$205.9M

TTM

Current Assets

$380.7M

Q3 2024

Current Liabilities

$106.9M

Q3 2024

Current Ratio

356.11%

Q3 2024

Total Assets

$3.317B

Q3 2024

Total Liabilities

$1.585B

Q3 2024

Book Value

$1.732B

Q3 2024

Cash

$51.54M

Q3 2024

P/E

19.86

Nov 14, 2024 EST

Free Cash Flow

$254.6M

TTM

Revenues

Revenue YoY Change

Revenues

Concept	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002
Revenue	$1.125B	$1.128B	$1.087B	$943.4M	$963.0M	$975.8M	$1.041B	$882.1M	$806.2M	$713.5M	$595.6M	$616.9M	$441.1M	$336.5M	$292.6M	$294.3M	$306.6M	$296.0M	$296.7M	$289.1M	$85.30M	$71.70M	$46.20M
YoY Change	-0.21%	3.76%	15.21%	-2.04%	-1.31%	-6.28%	18.04%	9.4%	13.01%	19.78%	-3.45%	39.86%	31.08%	15.01%	-0.58%	-4.01%	3.58%	-0.24%	2.63%	238.92%	18.97%	55.19%

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002
Revenue	$1.125B	$1.128B	$1.087B	$943.4M	$963.0M	$975.8M	$1.041B	$882.1M	$806.2M	$713.5M	$595.6M	$616.9M	$441.1M	$336.5M	$292.6M	$294.3M	$306.6M	$296.0M	$296.7M	$289.1M	$85.30M	$71.70M	$46.20M
Cost Of Revenue	$500.9M	$502.4M	$466.2M	$395.9M	$410.8M	$420.2M	$464.7M	$381.8M	$339.0M	$308.4M	$261.8M	$276.4M	$213.7M	$165.6M	$139.2M	$138.9M	$146.0M	$139.9M	$139.4M	$139.0M	$36.20M	$27.00M	$18.70M
Gross Profit	$624.4M	$625.3M	$620.6M	$547.5M	$552.2M	$555.6M	$576.5M	$500.3M	$467.2M	$406.2M	$335.6M	$343.7M	$227.4M	$170.9M	$153.4M	$155.4M	$160.6M	$156.1M	$157.2M	$150.1M	$49.10M	$44.70M	$27.50M
Gross Profit Margin	55.49%	55.45%	57.11%	58.03%	57.34%	56.94%	55.37%	56.72%	57.95%	56.94%	56.33%	55.72%	51.55%	50.78%	52.44%	52.8%	52.38%	52.74%	52.98%	51.92%	57.56%	62.34%	59.52%

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002
Selling, General & Admin	$259.5M	$252.4M	$265.9M	$226.1M	$236.3M	$227.8M	$230.0M	$201.5M	$180.8M	$179.2M	$133.4M	$142.1M	$113.8M	$84.90M	$65.10M	$69.30M	$65.10M	$59.40M	$53.20M	$49.90M	$25.00M	$23.20M	$13.80M
YoY Change	2.79%	-5.06%	17.58%	-4.32%	3.73%	-0.96%	14.14%	11.45%	0.89%	34.33%	-6.12%	24.87%	34.04%	30.41%	-6.06%	6.45%	9.6%	11.65%	6.61%	99.6%	7.76%	68.12%
% of Gross Profit	41.55%	40.37%	42.84%	41.3%	42.79%	41.0%	39.9%	40.28%	38.7%	44.11%	39.76%	41.34%	50.05%	49.68%	42.43%	44.59%	40.54%	38.05%	33.84%	33.24%	50.92%	51.9%	50.18%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$30.68M	$32.63M	$32.09M	$30.16M	$29.00M	$31.78M	$33.43M	$25.79M	$23.68M	$17.74M	$13.49M	$13.24M	$10.73M	$10.11M	$11.45M	$11.20M	$11.00M	$10.40M	$10.80M	$9.800M	$5.400M	$5.300M	$5.500M
YoY Change	-5.98%	1.66%	6.39%	4.03%	-8.76%	-4.93%	29.6%	8.94%	33.46%	31.54%	1.9%	23.3%	6.19%	-11.72%	2.23%	1.82%	5.77%	-3.7%	10.2%	81.48%	1.89%	-3.64%
% of Gross Profit	4.91%	5.22%	5.17%	5.51%	5.25%	5.72%	5.8%	5.16%	5.07%	4.37%	4.02%	3.85%	4.72%	5.92%	7.46%	7.21%	6.85%	6.66%	6.87%	6.53%	11.0%	11.86%	20.0%
Operating Expenses	$282.0M	$647.7M	$290.7M	$250.1M	$261.1M	$488.1M	$361.0M	$294.6M	$206.9M	$198.7M	$146.9M	$151.9M	$124.6M	$94.73M	$75.12M	$78.10M	$73.60M	$67.50M	$64.10M	$59.70M	$30.50M	$28.50M	$17.80M
YoY Change	-56.46%	122.79%	16.26%	-4.21%	-46.51%	35.19%	22.53%	42.41%	4.14%	35.21%	-3.24%	21.91%	31.49%	26.11%	-3.82%	6.11%	9.04%	5.3%	7.37%	95.74%	7.02%	60.11%
Operating Profit	$342.4M	-$22.42M	$329.9M	$297.4M	$291.2M	$67.50M	$215.5M	$205.6M	$260.3M	$207.6M	$188.6M	$191.9M	$102.8M	$76.15M	$78.33M	$77.30M	$87.00M	$88.60M	$93.10M	$90.40M	$18.60M	$16.20M	$9.700M
YoY Change	-1627.68%	-106.79%	10.93%	2.15%	331.32%	-68.67%	4.78%	-21.0%	25.42%	10.04%	-1.7%	86.62%	35.04%	-2.78%	1.33%	-11.15%	-1.81%	-4.83%	2.99%	386.02%	14.81%	67.01%

Interest Expenses

Interest Expenses To Operating Income %

Other Expense/Income

Interest & Other Expense/Income

Concept	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002
Interest Expense	$5.200M	-$69.16M	-$64.29M	-$82.30M	-$96.20M	-$105.1M	-$105.9M	-$93.30M	-$85.20M	-$81.20M	-$68.60M	-$84.40M	-$41.30M	-$27.30M	-$22.90M	-$28.40M	-$37.40M	-$39.50M	-$36.30M	-$44.70M	-$9.900M	-$9.700M	-$8.800M
YoY Change	-107.52%	7.59%	-21.89%	-14.45%	-8.47%	-0.76%	13.5%	9.51%	4.93%	18.37%	-18.72%	104.36%	51.28%	19.21%	-19.37%	-24.06%	-5.32%	8.82%	-18.79%	351.52%	2.06%	10.23%
% of Operating Profit	1.52%		-19.49%	-27.67%	-33.04%	-155.7%	-49.15%	-45.37%	-32.73%	-39.12%	-36.37%	-43.98%	-40.17%	-35.85%	-29.24%	-36.74%	-42.99%	-44.58%	-38.99%	-49.45%	-53.23%	-59.88%	-90.72%
Other Income/Expense, Net	$756.0K	-$2.336M	-$1.052M	$1.366M	-$1.625M	-$476.0K	$392.0K	-$30.00K											$0.00		$0.00	$0.00
YoY Change	-132.36%	122.05%	-177.01%	-184.06%	241.39%	-221.43%	-1406.67%

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002
Pretax Income	$276.0M	-$93.92M	$262.5M	$204.1M	$191.2M	-$38.06M	$107.1M	$110.9M	$157.2M	$127.5M	$101.7M	$106.0M	$61.16M	$48.53M	$52.73M	-$200.4M	$49.60M	$49.20M	$47.60M	$18.80M	$7.300M	$5.800M	$900.0K
YoY Change	-393.91%	-135.78%	28.58%	6.78%	-602.3%	-135.54%	-3.4%	-29.48%	23.32%	25.27%	-4.04%	73.38%	26.02%	-7.98%	-126.31%	-504.03%	0.81%	3.36%	153.19%	157.53%	25.86%	544.44%
Income Tax	$66.69M	-$11.61M	$57.08M	$39.43M	$48.87M	-$2.255M	-$232.5M	$41.46M	$57.28M	$49.20M	$29.13M	$40.53M	$23.95M	$19.35M	$20.66M	-$10.90M	$18.60M	$17.00M	$21.30M	$8.600M	$2.900M	$3.300M	$300.0K
% Of Pretax Income	24.16%		21.75%	19.32%	25.57%		-217.1%	37.4%	36.44%	38.6%	28.63%	38.22%	39.15%	39.87%	39.19%		37.5%	34.55%	44.75%	45.74%	39.73%	56.9%	33.33%
Net Earnings	$209.3M	-$82.31M	$205.4M	$164.7M	$142.3M	-$35.80M	$339.6M	$69.40M	$99.91M	$78.26M	$72.62M	$65.51M	$37.21M	$29.22M	$32.12M	-$186.8M	$33.90M	$36.10M	$26.30M	$10.20M	$4.400M	-$14.90M	$600.0K
YoY Change	-354.34%	-140.07%	24.71%	15.74%	-497.43%	-110.54%	389.33%	-30.54%	27.66%	7.77%	10.85%	76.03%	27.35%	-9.01%	-117.19%	-651.03%	-6.09%	37.26%	157.84%	131.82%	-129.53%	-2583.33%
Net Earnings / Revenue	18.6%	-7.3%	18.9%	17.46%	14.77%	-3.67%	32.61%	7.87%	12.39%	10.97%	12.19%	10.62%	8.44%	8.68%	10.98%	-63.47%	11.06%	12.2%	8.86%	3.53%	5.16%	-20.78%	1.3%
Basic Earnings Per Share	$4.21	-$1.65	$4.09	$3.28	$2.81	-$0.69	$6.40	$1.31	$1.89	$1.50	$1.41	$1.29	$0.74	$0.58	$0.64
Diluted Earnings Per Share	$4.17	-$1.65	$4.04	$3.25	$2.78	-$0.69	$6.34	$1.30	$1.88	$1.49	$1.39	$1.27	$0.73	$0.58	$0.64	-$3.743M	$678.0K	$722.0K	$526.0K	$370.9K	$165.4K	-$298.0K	$12.00K

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003
Cash & Short-Term Investments	$46.47M	$58.49M	$27.19M	$32.30M	$94.80M	$27.50M	$32.50M	$41.90M	$27.20M	$21.30M	$28.30M	$15.70M	$19.00M	$13.30M	$41.10M	$35.20M	$6.100M	$13.80M	$8.200M	$5.300M	$3.400M	$3.500M
YoY Change	-20.55%	115.15%	-15.84%	-65.93%	244.73%	-15.38%	-22.43%	54.04%	27.7%	-24.73%	80.25%	-17.37%	42.86%	-67.64%	16.76%	477.05%	-55.8%	68.29%	54.72%	55.88%	-2.86%
Cash & Equivalents	$46.47M	$58.49M	$27.19M	$32.30M	$94.80M	$27.50M	$32.50M	$41.90M	$27.20M	$21.30M	$28.30M	$15.70M	$19.00M	$13.30M	$41.10M	$35.20M	$6.100M	$13.80M	$8.200M	$5.300M	$3.400M	$3.500M
Short-Term Investments
Other Short-Term Assets	$13.08M	$4.117M	$6.410M	$7.900M	$4.400M	$4.700M	$11.50M	$40.20M	$35.30M	$18.50M	$18.20M	$15.20M	$16.70M	$10.10M	$12.70M	$6.500M	$5.400M	$4.600M	$3.900M	$8.900M	$1.800M	$1.300M
YoY Change	217.76%	-35.77%	-18.86%	79.55%	-6.38%	-59.13%	-71.39%	13.88%	90.81%	1.65%	19.74%	-8.98%	65.35%	-20.47%	95.38%	20.37%	17.39%	17.95%	-56.18%	394.44%	38.46%
Inventory	$138.7M	$162.1M	$120.3M	$115.0M	$116.0M	$119.9M	$118.5M	$115.6M	$91.30M	$74.00M	$65.60M	$60.20M	$51.10M	$39.80M	$27.70M	$25.90M	$29.70M	$30.20M	$33.80M	$24.80M	$10.70M	$5.600M
Prepaid Expenses
Receivables	$176.8M	$167.0M	$139.3M	$114.6M	$150.0M	$148.1M	$140.1M	$135.3M	$94.00M	$85.50M	$65.10M	$72.40M	$50.90M	$43.70M	$29.00M	$34.90M	$42.80M	$33.50M	$38.20M	$35.10M	$13.00M	$13.00M
Other Receivables	$0.00	$0.00	$0.00	$100.0K	$500.0K	$700.0K	$800.0K	$1.400M	$1.200M	$2.400M	$0.00	$700.0K	$9.300M	$700.0K	$1.600M	$1.100M	$1.400M	$1.700M	$1.800M	$800.0K	$400.0K	$200.0K
Total Short-Term Assets	$375.0M	$391.7M	$293.3M	$269.8M	$365.7M	$300.9M	$303.5M	$334.4M	$249.0M	$201.7M	$177.2M	$164.2M	$147.0M	$107.6M	$112.2M	$103.6M	$85.40M	$83.80M	$86.00M	$74.90M	$29.30M	$23.60M
YoY Change	-4.26%	33.58%	8.7%	-26.22%	21.54%	-0.86%	-9.24%	34.3%	23.45%	13.83%	7.92%	11.7%	36.62%	-4.1%	8.3%	21.31%	1.91%	-2.56%	14.82%	155.63%	24.15%
Property, Plant & Equipment	$89.33M	$89.54M	$98.53M	$102.8M	$90.70M	$51.20M	$52.60M	$50.60M	$15.50M	$13.70M	$9.600M	$9.900M	$1.300M	$1.400M	$1.400M	$1.400M	$1.400M	$1.400M	$1.700M	$2.300M	$900.0K	$600.0K
YoY Change	-0.23%	-9.13%	-4.15%	13.34%	77.15%	-2.66%	3.95%	226.45%	13.14%	42.71%	-3.03%	661.54%	-7.14%	0.0%	0.0%	0.0%	0.0%	-17.65%	-26.09%	155.56%	50.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$5.725M	$3.005M	$3.273M	$2.900M	$3.000M	$3.100M	$3.600M	$7.500M	$1.300M	$1.200M	$23.20M	$24.90M	$35.70M	$6.600M	$12.00M	$13.10M	$6.800M	$10.10M	$15.80M	$16.00M	$2.800M	$5.200M
YoY Change	90.52%	-8.19%	12.86%	-3.33%	-3.23%	-13.89%	-52.0%	476.92%	8.33%	-94.83%	-6.83%	-30.25%	440.91%	-45.0%	-8.4%	92.65%	-32.67%	-36.08%	-1.25%	471.43%	-46.15%
Total Long-Term Assets	$2.943B	$2.962B	$3.377B	$3.160B	$3.148B	$3.140B	$3.457B	$3.577B	$2.700B	$2.440B	$1.619B	$1.576B	$1.611B	$949.3M	$679.2M	$697.8M	$963.8M	$979.6M	$952.6M	$921.7M	$296.1M	$120.3M
YoY Change	-0.63%	-12.3%	6.9%	0.36%	0.26%	-9.17%	-3.35%	32.49%	10.63%	50.78%	2.72%	-2.22%	69.74%	39.77%	-2.67%	-27.6%	-1.61%	2.83%	3.35%	211.28%	146.13%
Total Assets	$3.318B	$3.354B	$3.671B	$3.429B	$3.514B	$3.441B	$3.761B	$3.911B	$2.949B	$2.642B	$1.796B	$1.740B	$1.758B	$1.057B	$791.4M	$801.4M	$1.049B	$1.063B	$1.039B	$996.6M	$325.4M	$143.9M
YoY Change
Accounts Payable	$38.98M	$62.74M	$55.76M	$46.00M	$62.40M	$56.60M	$61.40M	$70.20M	$38.30M	$46.10M	$48.30M	$51.40M	$26.70M	$21.60M	$12.80M	$15.90M	$20.50M	$19.30M	$18.10M	$21.70M	$5.300M	$4.400M
YoY Change	-37.88%	12.52%	21.22%	-26.28%	10.25%	-7.82%	-12.54%	83.29%	-16.92%	-4.55%	-6.03%	92.51%	23.61%	68.75%	-19.5%	-22.44%	6.22%	6.63%	-16.59%	309.43%	20.45%
Accrued Expenses	$74.01M	$84.49M	$82.24M	$71.90M	$81.20M	$70.30M	$59.90M	$69.00M	$58.40M	$50.30M	$34.20M	$44.80M	$36.60M	$32.10M	$13.30M	$14.10M	$13.80M	$18.10M	$12.10M	$11.60M	$6.600M	$9.100M
YoY Change	-12.41%	2.74%	14.38%	-11.45%	15.5%	17.36%	-13.19%	18.15%	16.1%	47.08%	-23.66%	22.4%	14.02%	141.35%	-5.67%	2.17%	-23.76%	49.59%	4.31%	75.76%	-27.47%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.494M	$2.834M	$2.752M	$2.600M	$1.200M									$0.00	$29.60M	$3.600M	$3.600M	$3.600M	$3.700M	$3.700M	$2.000M	$19.60M
YoY Change	-47.28%	2.98%	5.85%	116.67%										-100.0%	722.22%	0.0%	0.0%	-2.7%	0.0%	85.0%	-89.8%
Total Short-Term Liabilities	$117.0M	$160.7M	$143.4M	$122.1M	$149.9M	$127.0M	$123.2M	$162.0M	$106.7M	$99.00M	$84.40M	$96.70M	$63.90M	$54.20M	$55.70M	$34.20M	$37.90M	$40.90M	$35.70M	$37.00M	$13.80M	$33.10M
YoY Change	-27.17%	12.06%	17.46%	-18.55%	18.03%	3.08%	-23.95%	51.83%	7.78%	17.3%	-12.72%	51.33%	17.9%	-2.69%	62.87%	-9.76%	-7.33%	14.57%	-3.51%	168.12%	-58.31%
Long-Term Debt	$1.126B	$1.347B	$1.481B	$1.487B	$1.735B	$1.799B	$1.993B	$2.194B	$1.625B	$1.561B	$934.4M	$970.9M	$1.124B	$486.9M	$294.6M	$374.8M	$407.7M	$459.8M	$494.9M	$491.6M	$146.7M	$61.40M
YoY Change	-16.44%	-9.03%	-0.36%	-14.32%	-3.54%	-9.75%	-9.15%	34.97%	4.1%	67.09%	-3.76%	-13.61%	130.83%	65.27%	-21.4%	-8.07%	-11.33%	-7.09%	0.67%	235.11%	138.93%
Other Long-Term Liabilities	$16.71M	$18.04M	$23.57M	$28.30M	$50.30M	$20.10M	$23.30M	$18.00M	$2.800M	$2.500M	$300.0K						$2.400M	$2.800M	$0.00			$800.0K
YoY Change	-7.36%	-23.46%	-16.71%	-43.74%	150.25%	-13.73%	29.44%	542.86%	12.0%	733.33%							-14.29%
Total Long-Term Liabilities	$1.143B	$1.365B	$1.505B	$1.515B	$1.785B	$1.819B	$2.016B	$2.212B	$1.628B	$1.564B	$934.7M	$970.9M	$1.124B	$486.9M	$294.6M	$374.8M	$410.1M	$462.6M	$494.9M	$491.6M	$146.7M	$62.20M
YoY Change	-16.32%	-9.25%	-0.66%	-15.15%	-1.84%	-9.8%	-8.83%	35.85%	4.11%	67.31%	-3.73%	-13.61%	130.83%	65.27%	-21.4%	-8.61%	-11.35%	-6.53%	0.67%	235.11%	135.85%
Total Liabilities	$1.663B	$1.907B	$2.093B	$2.071B	$2.343B	$2.345B	$2.582B	$3.089B	$2.205B	$2.014B	$1.232B	$1.262B	$1.356B	$695.1M	$462.4M	$507.0M	$570.1M	$618.1M	$629.2M	$614.6M	$199.4M	$99.10M
YoY Change	-12.76%	-8.91%	1.07%	-11.61%	-0.1%	-9.17%	-16.41%	40.11%	9.44%	63.46%	-2.35%	-6.91%	95.01%	50.32%	-8.8%	-11.07%	-7.77%	-1.76%	2.38%	208.22%	101.21%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

Treasury Stock Shares

Stock Issuance & Repurchase

Ownership Data

Concept	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Basic Shares Outstanding	49.76M shares	49.89M shares	50.26M shares	50.21M shares	50.72M shares	52.07M shares	53.10M shares	52.98M shares	52.75M shares	52.17M shares	51.64M shares	50.63M shares	50.27M shares	50.08M shares	50.01M shares
Diluted Shares Outstanding	50.18M shares	49.89M shares	50.84M shares	50.61M shares	51.14M shares	52.07M shares	53.53M shares	53.36M shares	53.14M shares	52.67M shares	52.35M shares	51.44M shares	50.75M shares	50.34M shares	50.09M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Free Cash Flow Margin

Dividends

Stock Price

Market Cap: $4.0903 Billion

About Prestige Consumer Healthcare Inc

Prestige Consumer Healthcare, Inc. engages in the marketing, sale, and distribution of pharmaceutical drugs and consumer products. The company is headquartered in Tarrytown, New York and currently employs 570 full-time employees. The company went IPO on 2005-02-10. The firm is engaged in the development, manufacturing, marketing, sales and distribution of over-the-counter (OTC) health and personal care products to mass merchandisers, drug, food, dollar, convenience, club and e-commerce stores in North America (the United States and Canada) and in Australia and certain other international markets. The company operates through two segments: North American OTC Healthcare and International OTC Healthcare. Its diverse portfolio of brands includes Monistat and Summer’s Eve women's health products, BC and Goody's pain relievers, Clear Eyes and TheraTears eye care products, DenTek specialty oral care products, Dramamine motion sickness treatments, Fleet enemas and glycerin suppositories, Chloraseptic and Luden's sore throat treatments and drops, Compound W wart removal products, Boudreaux’s Butt Paste diaper rash ointments, Nix lice treatment products, Debrox earwax remover, and others.

Industry: Pharmaceutical Preparations Peers: Arvinas Inc Pacira Biosciences Inc Corcept Therapeutics Inc Elanco Animal Health Inc Harmony Biosciences Holdings Inc Intra-Cellular Therapies Inc Johnson & Johnson